The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...
Spark Biomedical, a leader in wearable neurostimulation technology, announces the receipt of its Medical Device License from Health Canada for Sparrow AscentTM, ...